Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NOB1 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
mRNA | AURKA | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
mRNA | DOLK | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-05 |
mRNA | LMNA | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0001 |
mRNA | BOLA3 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | EIF2S2 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | CCT3 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
mRNA | EMC6 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
mRNA | PFDN2 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
mRNA | DUS2 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |